Abstract-Structural alterations of subcutaneous small-resistance arteries are associated with a worse clinical prognosis in hypertension and non-insulin-dependent diabetes mellitus. The effects of the direct renin inhibitor aliskiren on microvascular structure were never previously evaluated. Therefore, we investigated the effects of aliskiren in comparison with those of an extensively used angiotensin-converting enzyme inhibitor, ramipril, on peripheral subcutaneous small-resistance artery morphology, retinal arteriolar structure, and capillary density in a population of patients with non-insulin-dependent diabetes mellitus. Sixteen patients with mild essential hypertension and with a previous diagnosis of non-insulin-dependent diabetes mellitus were included in the study. Patients were then randomized to 1 of the 2 active treatments (aliskiren 150 mg once daily, n=9; or ramipril 5 mg once daily, n=7). Each patient underwent a biopsy of the subcutaneous fat from the gluteal region, an evaluation of retinal artery morphology (scanning laser Doppler flowmetry), and capillary density (capillaroscopy), at baseline and after 1 year of treatment. Subcutaneous small arteries were dissected and mounted on a pressurized micromyograph, and the media-to-lumen ratio was evaluated. A similar office blood pressure-lowering effect and a similar reduction of the wall-to-lumen ratio of retinal arterioles were observed with the 2 drugs. Aliskiren significantly reduced media-to-lumen ratio of subcutaneous small-resistance arteries, whereas ramipril-induced reduction of media to lumen ratio was not statistically significant. No relevant effect on capillary density was observed. In conclusion, treatment with aliskiren or ramipril was associated with a correction of microvascular structural alterations in patients with non-insulin-dependent diabetes mellitus. An increased media-to-lumen ratio of subcutaneous smallresistance arteries is a potent predictor of cardiovascular events in patients with increased blood pressure values, [10][11][12] part of them being also diabetics.10,11 Antihypertensive treatment is able to regress structural alterations in subcutaneous small-resistance arteries of essential hypertensive patients 13 ; however, despite similar blood pressure-lowering effects, angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptors blockers, and calcium channel blockers proved to be more effective than diuretics and β-blockers in terms of reduction in the media-to-lumen ratio. 13 The extent of the reduction in the media-to-lumen ratio of subcutaneous small-resistance arteries was recently demonstrated to be an independent predictor of cardiovascular events in essential hypertension. 14 However, in patients with diabetes mellitus, it seems more difficult to obtain a complete regression of small-resistance artery structural alterations, despite prolonged treatment.
15-18A possible explanation is related to the presence, in patients with diabetes mellitus, of hypertrophic remodeling of small arteries, which repre...